http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0625908-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6418
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
filingDate 1993-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db156fc03a1c2d8f4ac37df676317366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5b9002724bc5ae386fb2406ecfd347
publicationDate 1997-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0625908-B1
titleOfInvention Antidote for hirudin and synthetic thrombin inhibitors
abstract The invention relates to an antidote for hirudin and synthetic thrombin inhibitors; the antidote contains a compound that splits prothrombin into meizothrombin, a prothrombin intermediate, a pharmacologically acceptable salt thereof or a mixture of these compounds, together with conventional vehicles and/or diluents. The present invention also relates to the application of a compound that splits prothrombin into meizothrombin, a prothrombin intermediate, or a pharmacologically acceptable salt thereof or a mixture of these compounds, together with conventional vehicles and/or diluents as an antidote for hirudin and synthetic thrombin inhibitors or for the preparation of an antidote for hirudin and synthetic thrombin inhibitors.
priorityDate 1992-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18968514
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07204
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ71U07
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID744785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128793030
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID6421
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404015
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7056
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID465887
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID374258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128587714
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21824
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108180329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID617960
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20637
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID114423
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID6421
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1MBI9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395086
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14071
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5657732
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5W7P8
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID40353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5G2QPN5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2155
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO35370
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP05807
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID40353
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID359826
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID260320
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID607661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15306
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06579
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395980
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO57214
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83580

Total number of triples: 93.